The present study was conducted to find the prevalence of HCV antibody in b
lood donors with an aim to provide safe blood for transfusion. A total of 4
4,086 blood samples from healthy blood donors was screened for HCV antibody
by third generation ELISA assay and a prevalence of 0.53 per cent was foun
d in our study. We suggest that routine screening of all donor blood should
be done.